Global Nano Antibodies Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Nano Antibodies market size was valued at USD 293.9 million in 2023 and is forecast to a readjusted size of USD 1345 million by 2030 with a CAGR of 24.3% during review period.
Nanoantibodies or 'nAb' are single-domain VHH antibodies derived from camelidae (camels, llamas, alpacas, etc.). Compared with conventional monoclonal and polyclonal antibodies, nAbs have the following advantages:
Small size (~15kd)
High affinity (frequently nanomolar range)
High specificity
Unsurpassed stability
?????????????????????????????????????????????????????
The Global Info Research report includes an overview of the development of the Nano Antibodies industry chain, the market status of Disease detection in vitro (Monovalent Nanobody, Multivalent and multispecific Nanobodies), Non-invasive diagnosis in vivo (Monovalent Nanobody, Multivalent and multispecific Nanobodies), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nano Antibodies.
Regionally, the report analyzes the Nano Antibodies markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nano Antibodies market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nano Antibodies market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nano Antibodies industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monovalent Nanobody, Multivalent and multispecific Nanobodies).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nano Antibodies market.
Regional Analysis: The report involves examining the Nano Antibodies market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nano Antibodies market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nano Antibodies:
Company Analysis: Report covers individual Nano Antibodies players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nano Antibodies This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Disease detection in vitro, Non-invasive diagnosis in vivo).
Technology Analysis: Report covers specific technologies relevant to Nano Antibodies. It assesses the current state, advancements, and potential future developments in Nano Antibodies areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nano Antibodies market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nano Antibodies market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Nano Antibodies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nano Antibodies, with revenue, gross margin and global market share of Nano Antibodies from 2019 to 2024.
Chapter 3, the Nano Antibodies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Nano Antibodies market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nano Antibodies.
Chapter 13, to describe Nano Antibodies research findings and conclusion.
Nanoantibodies or 'nAb' are single-domain VHH antibodies derived from camelidae (camels, llamas, alpacas, etc.). Compared with conventional monoclonal and polyclonal antibodies, nAbs have the following advantages:
Small size (~15kd)
High affinity (frequently nanomolar range)
High specificity
Unsurpassed stability
?????????????????????????????????????????????????????
The Global Info Research report includes an overview of the development of the Nano Antibodies industry chain, the market status of Disease detection in vitro (Monovalent Nanobody, Multivalent and multispecific Nanobodies), Non-invasive diagnosis in vivo (Monovalent Nanobody, Multivalent and multispecific Nanobodies), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nano Antibodies.
Regionally, the report analyzes the Nano Antibodies markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nano Antibodies market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nano Antibodies market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nano Antibodies industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monovalent Nanobody, Multivalent and multispecific Nanobodies).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nano Antibodies market.
Regional Analysis: The report involves examining the Nano Antibodies market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nano Antibodies market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nano Antibodies:
Company Analysis: Report covers individual Nano Antibodies players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nano Antibodies This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Disease detection in vitro, Non-invasive diagnosis in vivo).
Technology Analysis: Report covers specific technologies relevant to Nano Antibodies. It assesses the current state, advancements, and potential future developments in Nano Antibodies areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nano Antibodies market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Nano Antibodies market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Monovalent Nanobody
- Multivalent and multispecific Nanobodies
- Fusion Nanobody
- Disease detection in vitro
- Non-invasive diagnosis in vivo
- Tumor targeted therapy
- Nervous system disease
- Circulatory disease
- Infectious disease
- Other
- Merck KGaA
- Sanofi (Ablynx)
- Alphamab Oncology
- Novartis AG
- Genscript
- Taisho Pharmaceutical Holdings
- Sensei Biotherapeutics, Inc.
- Cusabio Technology LLC.
- ChromoTek GmbH
- Beroni Group
- ExeVir Bio BV
- Absolute Antibody
- Alpalife (Shenzhen kangti Co., Ltd.)
- DiosCURE Therapeutics SE
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc. (BioLegend, Inc.)
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Nano Antibodies product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nano Antibodies, with revenue, gross margin and global market share of Nano Antibodies from 2019 to 2024.
Chapter 3, the Nano Antibodies competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Nano Antibodies market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nano Antibodies.
Chapter 13, to describe Nano Antibodies research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Nano Antibodies
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Nano Antibodies by Type
1.3.1 Overview: Global Nano Antibodies Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Nano Antibodies Consumption Value Market Share by Type in 2023
1.3.3 Monovalent Nanobody
1.3.4 Multivalent and multispecific Nanobodies
1.3.5 Fusion Nanobody
1.4 Global Nano Antibodies Market by Application
1.4.1 Overview: Global Nano Antibodies Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Disease detection in vitro
1.4.3 Non-invasive diagnosis in vivo
1.4.4 Tumor targeted therapy
1.4.5 Nervous system disease
1.4.6 Circulatory disease
1.4.7 Infectious disease
1.4.8 Other
1.5 Global Nano Antibodies Market Size & Forecast
1.6 Global Nano Antibodies Market Size and Forecast by Region
1.6.1 Global Nano Antibodies Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Nano Antibodies Market Size by Region, (2019-2030)
1.6.3 North America Nano Antibodies Market Size and Prospect (2019-2030)
1.6.4 Europe Nano Antibodies Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Nano Antibodies Market Size and Prospect (2019-2030)
1.6.6 South America Nano Antibodies Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Nano Antibodies Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Merck KGaA
2.1.1 Merck KGaA Details
2.1.2 Merck KGaA Major Business
2.1.3 Merck KGaA Nano Antibodies Product and Solutions
2.1.4 Merck KGaA Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck KGaA Recent Developments and Future Plans
2.2 Sanofi (Ablynx)
2.2.1 Sanofi (Ablynx) Details
2.2.2 Sanofi (Ablynx) Major Business
2.2.3 Sanofi (Ablynx) Nano Antibodies Product and Solutions
2.2.4 Sanofi (Ablynx) Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi (Ablynx) Recent Developments and Future Plans
2.3 Alphamab Oncology
2.3.1 Alphamab Oncology Details
2.3.2 Alphamab Oncology Major Business
2.3.3 Alphamab Oncology Nano Antibodies Product and Solutions
2.3.4 Alphamab Oncology Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Alphamab Oncology Recent Developments and Future Plans
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG Nano Antibodies Product and Solutions
2.4.4 Novartis AG Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis AG Recent Developments and Future Plans
2.5 Genscript
2.5.1 Genscript Details
2.5.2 Genscript Major Business
2.5.3 Genscript Nano Antibodies Product and Solutions
2.5.4 Genscript Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Genscript Recent Developments and Future Plans
2.6 Taisho Pharmaceutical Holdings
2.6.1 Taisho Pharmaceutical Holdings Details
2.6.2 Taisho Pharmaceutical Holdings Major Business
2.6.3 Taisho Pharmaceutical Holdings Nano Antibodies Product and Solutions
2.6.4 Taisho Pharmaceutical Holdings Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Taisho Pharmaceutical Holdings Recent Developments and Future Plans
2.7 Sensei Biotherapeutics, Inc.
2.7.1 Sensei Biotherapeutics, Inc. Details
2.7.2 Sensei Biotherapeutics, Inc. Major Business
2.7.3 Sensei Biotherapeutics, Inc. Nano Antibodies Product and Solutions
2.7.4 Sensei Biotherapeutics, Inc. Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sensei Biotherapeutics, Inc. Recent Developments and Future Plans
2.8 Cusabio Technology LLC.
2.8.1 Cusabio Technology LLC. Details
2.8.2 Cusabio Technology LLC. Major Business
2.8.3 Cusabio Technology LLC. Nano Antibodies Product and Solutions
2.8.4 Cusabio Technology LLC. Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Cusabio Technology LLC. Recent Developments and Future Plans
2.9 ChromoTek GmbH
2.9.1 ChromoTek GmbH Details
2.9.2 ChromoTek GmbH Major Business
2.9.3 ChromoTek GmbH Nano Antibodies Product and Solutions
2.9.4 ChromoTek GmbH Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 ChromoTek GmbH Recent Developments and Future Plans
2.10 Beroni Group
2.10.1 Beroni Group Details
2.10.2 Beroni Group Major Business
2.10.3 Beroni Group Nano Antibodies Product and Solutions
2.10.4 Beroni Group Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Beroni Group Recent Developments and Future Plans
2.11 ExeVir Bio BV
2.11.1 ExeVir Bio BV Details
2.11.2 ExeVir Bio BV Major Business
2.11.3 ExeVir Bio BV Nano Antibodies Product and Solutions
2.11.4 ExeVir Bio BV Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 ExeVir Bio BV Recent Developments and Future Plans
2.12 Absolute Antibody
2.12.1 Absolute Antibody Details
2.12.2 Absolute Antibody Major Business
2.12.3 Absolute Antibody Nano Antibodies Product and Solutions
2.12.4 Absolute Antibody Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Absolute Antibody Recent Developments and Future Plans
2.13 Alpalife (Shenzhen kangti Co., Ltd.)
2.13.1 Alpalife (Shenzhen kangti Co., Ltd.) Details
2.13.2 Alpalife (Shenzhen kangti Co., Ltd.) Major Business
2.13.3 Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Product and Solutions
2.13.4 Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Alpalife (Shenzhen kangti Co., Ltd.) Recent Developments and Future Plans
2.14 DiosCURE Therapeutics SE
2.14.1 DiosCURE Therapeutics SE Details
2.14.2 DiosCURE Therapeutics SE Major Business
2.14.3 DiosCURE Therapeutics SE Nano Antibodies Product and Solutions
2.14.4 DiosCURE Therapeutics SE Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 DiosCURE Therapeutics SE Recent Developments and Future Plans
2.15 Thermo Fisher Scientific Inc.
2.15.1 Thermo Fisher Scientific Inc. Details
2.15.2 Thermo Fisher Scientific Inc. Major Business
2.15.3 Thermo Fisher Scientific Inc. Nano Antibodies Product and Solutions
2.15.4 Thermo Fisher Scientific Inc. Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.16 PerkinElmer Inc. (BioLegend, Inc.)
2.16.1 PerkinElmer Inc. (BioLegend, Inc.) Details
2.16.2 PerkinElmer Inc. (BioLegend, Inc.) Major Business
2.16.3 PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Product and Solutions
2.16.4 PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 PerkinElmer Inc. (BioLegend, Inc.) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Nano Antibodies Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Nano Antibodies by Company Revenue
3.2.2 Top 3 Nano Antibodies Players Market Share in 2023
3.2.3 Top 6 Nano Antibodies Players Market Share in 2023
3.3 Nano Antibodies Market: Overall Company Footprint Analysis
3.3.1 Nano Antibodies Market: Region Footprint
3.3.2 Nano Antibodies Market: Company Product Type Footprint
3.3.3 Nano Antibodies Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Nano Antibodies Consumption Value and Market Share by Type (2019-2024)
4.2 Global Nano Antibodies Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Nano Antibodies Consumption Value Market Share by Application (2019-2024)
5.2 Global Nano Antibodies Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Nano Antibodies Consumption Value by Type (2019-2030)
6.2 North America Nano Antibodies Consumption Value by Application (2019-2030)
6.3 North America Nano Antibodies Market Size by Country
6.3.1 North America Nano Antibodies Consumption Value by Country (2019-2030)
6.3.2 United States Nano Antibodies Market Size and Forecast (2019-2030)
6.3.3 Canada Nano Antibodies Market Size and Forecast (2019-2030)
6.3.4 Mexico Nano Antibodies Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Nano Antibodies Consumption Value by Type (2019-2030)
7.2 Europe Nano Antibodies Consumption Value by Application (2019-2030)
7.3 Europe Nano Antibodies Market Size by Country
7.3.1 Europe Nano Antibodies Consumption Value by Country (2019-2030)
7.3.2 Germany Nano Antibodies Market Size and Forecast (2019-2030)
7.3.3 France Nano Antibodies Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Nano Antibodies Market Size and Forecast (2019-2030)
7.3.5 Russia Nano Antibodies Market Size and Forecast (2019-2030)
7.3.6 Italy Nano Antibodies Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Nano Antibodies Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Nano Antibodies Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Nano Antibodies Market Size by Region
8.3.1 Asia-Pacific Nano Antibodies Consumption Value by Region (2019-2030)
8.3.2 China Nano Antibodies Market Size and Forecast (2019-2030)
8.3.3 Japan Nano Antibodies Market Size and Forecast (2019-2030)
8.3.4 South Korea Nano Antibodies Market Size and Forecast (2019-2030)
8.3.5 India Nano Antibodies Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Nano Antibodies Market Size and Forecast (2019-2030)
8.3.7 Australia Nano Antibodies Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Nano Antibodies Consumption Value by Type (2019-2030)
9.2 South America Nano Antibodies Consumption Value by Application (2019-2030)
9.3 South America Nano Antibodies Market Size by Country
9.3.1 South America Nano Antibodies Consumption Value by Country (2019-2030)
9.3.2 Brazil Nano Antibodies Market Size and Forecast (2019-2030)
9.3.3 Argentina Nano Antibodies Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Nano Antibodies Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Nano Antibodies Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Nano Antibodies Market Size by Country
10.3.1 Middle East & Africa Nano Antibodies Consumption Value by Country (2019-2030)
10.3.2 Turkey Nano Antibodies Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Nano Antibodies Market Size and Forecast (2019-2030)
10.3.4 UAE Nano Antibodies Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Nano Antibodies Market Drivers
11.2 Nano Antibodies Market Restraints
11.3 Nano Antibodies Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Nano Antibodies Industry Chain
12.2 Nano Antibodies Upstream Analysis
12.3 Nano Antibodies Midstream Analysis
12.4 Nano Antibodies Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Nano Antibodies
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Nano Antibodies by Type
1.3.1 Overview: Global Nano Antibodies Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Nano Antibodies Consumption Value Market Share by Type in 2023
1.3.3 Monovalent Nanobody
1.3.4 Multivalent and multispecific Nanobodies
1.3.5 Fusion Nanobody
1.4 Global Nano Antibodies Market by Application
1.4.1 Overview: Global Nano Antibodies Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Disease detection in vitro
1.4.3 Non-invasive diagnosis in vivo
1.4.4 Tumor targeted therapy
1.4.5 Nervous system disease
1.4.6 Circulatory disease
1.4.7 Infectious disease
1.4.8 Other
1.5 Global Nano Antibodies Market Size & Forecast
1.6 Global Nano Antibodies Market Size and Forecast by Region
1.6.1 Global Nano Antibodies Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Nano Antibodies Market Size by Region, (2019-2030)
1.6.3 North America Nano Antibodies Market Size and Prospect (2019-2030)
1.6.4 Europe Nano Antibodies Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Nano Antibodies Market Size and Prospect (2019-2030)
1.6.6 South America Nano Antibodies Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Nano Antibodies Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Merck KGaA
2.1.1 Merck KGaA Details
2.1.2 Merck KGaA Major Business
2.1.3 Merck KGaA Nano Antibodies Product and Solutions
2.1.4 Merck KGaA Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck KGaA Recent Developments and Future Plans
2.2 Sanofi (Ablynx)
2.2.1 Sanofi (Ablynx) Details
2.2.2 Sanofi (Ablynx) Major Business
2.2.3 Sanofi (Ablynx) Nano Antibodies Product and Solutions
2.2.4 Sanofi (Ablynx) Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi (Ablynx) Recent Developments and Future Plans
2.3 Alphamab Oncology
2.3.1 Alphamab Oncology Details
2.3.2 Alphamab Oncology Major Business
2.3.3 Alphamab Oncology Nano Antibodies Product and Solutions
2.3.4 Alphamab Oncology Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Alphamab Oncology Recent Developments and Future Plans
2.4 Novartis AG
2.4.1 Novartis AG Details
2.4.2 Novartis AG Major Business
2.4.3 Novartis AG Nano Antibodies Product and Solutions
2.4.4 Novartis AG Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Novartis AG Recent Developments and Future Plans
2.5 Genscript
2.5.1 Genscript Details
2.5.2 Genscript Major Business
2.5.3 Genscript Nano Antibodies Product and Solutions
2.5.4 Genscript Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Genscript Recent Developments and Future Plans
2.6 Taisho Pharmaceutical Holdings
2.6.1 Taisho Pharmaceutical Holdings Details
2.6.2 Taisho Pharmaceutical Holdings Major Business
2.6.3 Taisho Pharmaceutical Holdings Nano Antibodies Product and Solutions
2.6.4 Taisho Pharmaceutical Holdings Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Taisho Pharmaceutical Holdings Recent Developments and Future Plans
2.7 Sensei Biotherapeutics, Inc.
2.7.1 Sensei Biotherapeutics, Inc. Details
2.7.2 Sensei Biotherapeutics, Inc. Major Business
2.7.3 Sensei Biotherapeutics, Inc. Nano Antibodies Product and Solutions
2.7.4 Sensei Biotherapeutics, Inc. Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Sensei Biotherapeutics, Inc. Recent Developments and Future Plans
2.8 Cusabio Technology LLC.
2.8.1 Cusabio Technology LLC. Details
2.8.2 Cusabio Technology LLC. Major Business
2.8.3 Cusabio Technology LLC. Nano Antibodies Product and Solutions
2.8.4 Cusabio Technology LLC. Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Cusabio Technology LLC. Recent Developments and Future Plans
2.9 ChromoTek GmbH
2.9.1 ChromoTek GmbH Details
2.9.2 ChromoTek GmbH Major Business
2.9.3 ChromoTek GmbH Nano Antibodies Product and Solutions
2.9.4 ChromoTek GmbH Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 ChromoTek GmbH Recent Developments and Future Plans
2.10 Beroni Group
2.10.1 Beroni Group Details
2.10.2 Beroni Group Major Business
2.10.3 Beroni Group Nano Antibodies Product and Solutions
2.10.4 Beroni Group Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Beroni Group Recent Developments and Future Plans
2.11 ExeVir Bio BV
2.11.1 ExeVir Bio BV Details
2.11.2 ExeVir Bio BV Major Business
2.11.3 ExeVir Bio BV Nano Antibodies Product and Solutions
2.11.4 ExeVir Bio BV Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 ExeVir Bio BV Recent Developments and Future Plans
2.12 Absolute Antibody
2.12.1 Absolute Antibody Details
2.12.2 Absolute Antibody Major Business
2.12.3 Absolute Antibody Nano Antibodies Product and Solutions
2.12.4 Absolute Antibody Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Absolute Antibody Recent Developments and Future Plans
2.13 Alpalife (Shenzhen kangti Co., Ltd.)
2.13.1 Alpalife (Shenzhen kangti Co., Ltd.) Details
2.13.2 Alpalife (Shenzhen kangti Co., Ltd.) Major Business
2.13.3 Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Product and Solutions
2.13.4 Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Alpalife (Shenzhen kangti Co., Ltd.) Recent Developments and Future Plans
2.14 DiosCURE Therapeutics SE
2.14.1 DiosCURE Therapeutics SE Details
2.14.2 DiosCURE Therapeutics SE Major Business
2.14.3 DiosCURE Therapeutics SE Nano Antibodies Product and Solutions
2.14.4 DiosCURE Therapeutics SE Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 DiosCURE Therapeutics SE Recent Developments and Future Plans
2.15 Thermo Fisher Scientific Inc.
2.15.1 Thermo Fisher Scientific Inc. Details
2.15.2 Thermo Fisher Scientific Inc. Major Business
2.15.3 Thermo Fisher Scientific Inc. Nano Antibodies Product and Solutions
2.15.4 Thermo Fisher Scientific Inc. Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.16 PerkinElmer Inc. (BioLegend, Inc.)
2.16.1 PerkinElmer Inc. (BioLegend, Inc.) Details
2.16.2 PerkinElmer Inc. (BioLegend, Inc.) Major Business
2.16.3 PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Product and Solutions
2.16.4 PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 PerkinElmer Inc. (BioLegend, Inc.) Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Nano Antibodies Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Nano Antibodies by Company Revenue
3.2.2 Top 3 Nano Antibodies Players Market Share in 2023
3.2.3 Top 6 Nano Antibodies Players Market Share in 2023
3.3 Nano Antibodies Market: Overall Company Footprint Analysis
3.3.1 Nano Antibodies Market: Region Footprint
3.3.2 Nano Antibodies Market: Company Product Type Footprint
3.3.3 Nano Antibodies Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Nano Antibodies Consumption Value and Market Share by Type (2019-2024)
4.2 Global Nano Antibodies Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Nano Antibodies Consumption Value Market Share by Application (2019-2024)
5.2 Global Nano Antibodies Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Nano Antibodies Consumption Value by Type (2019-2030)
6.2 North America Nano Antibodies Consumption Value by Application (2019-2030)
6.3 North America Nano Antibodies Market Size by Country
6.3.1 North America Nano Antibodies Consumption Value by Country (2019-2030)
6.3.2 United States Nano Antibodies Market Size and Forecast (2019-2030)
6.3.3 Canada Nano Antibodies Market Size and Forecast (2019-2030)
6.3.4 Mexico Nano Antibodies Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Nano Antibodies Consumption Value by Type (2019-2030)
7.2 Europe Nano Antibodies Consumption Value by Application (2019-2030)
7.3 Europe Nano Antibodies Market Size by Country
7.3.1 Europe Nano Antibodies Consumption Value by Country (2019-2030)
7.3.2 Germany Nano Antibodies Market Size and Forecast (2019-2030)
7.3.3 France Nano Antibodies Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Nano Antibodies Market Size and Forecast (2019-2030)
7.3.5 Russia Nano Antibodies Market Size and Forecast (2019-2030)
7.3.6 Italy Nano Antibodies Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Nano Antibodies Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Nano Antibodies Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Nano Antibodies Market Size by Region
8.3.1 Asia-Pacific Nano Antibodies Consumption Value by Region (2019-2030)
8.3.2 China Nano Antibodies Market Size and Forecast (2019-2030)
8.3.3 Japan Nano Antibodies Market Size and Forecast (2019-2030)
8.3.4 South Korea Nano Antibodies Market Size and Forecast (2019-2030)
8.3.5 India Nano Antibodies Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Nano Antibodies Market Size and Forecast (2019-2030)
8.3.7 Australia Nano Antibodies Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Nano Antibodies Consumption Value by Type (2019-2030)
9.2 South America Nano Antibodies Consumption Value by Application (2019-2030)
9.3 South America Nano Antibodies Market Size by Country
9.3.1 South America Nano Antibodies Consumption Value by Country (2019-2030)
9.3.2 Brazil Nano Antibodies Market Size and Forecast (2019-2030)
9.3.3 Argentina Nano Antibodies Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Nano Antibodies Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Nano Antibodies Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Nano Antibodies Market Size by Country
10.3.1 Middle East & Africa Nano Antibodies Consumption Value by Country (2019-2030)
10.3.2 Turkey Nano Antibodies Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Nano Antibodies Market Size and Forecast (2019-2030)
10.3.4 UAE Nano Antibodies Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Nano Antibodies Market Drivers
11.2 Nano Antibodies Market Restraints
11.3 Nano Antibodies Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Nano Antibodies Industry Chain
12.2 Nano Antibodies Upstream Analysis
12.3 Nano Antibodies Midstream Analysis
12.4 Nano Antibodies Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Nano Antibodies Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Nano Antibodies Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Nano Antibodies Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Nano Antibodies Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Merck KGaA Company Information, Head Office, and Major Competitors
Table 6. Merck KGaA Major Business
Table 7. Merck KGaA Nano Antibodies Product and Solutions
Table 8. Merck KGaA Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Merck KGaA Recent Developments and Future Plans
Table 10. Sanofi (Ablynx) Company Information, Head Office, and Major Competitors
Table 11. Sanofi (Ablynx) Major Business
Table 12. Sanofi (Ablynx) Nano Antibodies Product and Solutions
Table 13. Sanofi (Ablynx) Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Sanofi (Ablynx) Recent Developments and Future Plans
Table 15. Alphamab Oncology Company Information, Head Office, and Major Competitors
Table 16. Alphamab Oncology Major Business
Table 17. Alphamab Oncology Nano Antibodies Product and Solutions
Table 18. Alphamab Oncology Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Alphamab Oncology Recent Developments and Future Plans
Table 20. Novartis AG Company Information, Head Office, and Major Competitors
Table 21. Novartis AG Major Business
Table 22. Novartis AG Nano Antibodies Product and Solutions
Table 23. Novartis AG Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Novartis AG Recent Developments and Future Plans
Table 25. Genscript Company Information, Head Office, and Major Competitors
Table 26. Genscript Major Business
Table 27. Genscript Nano Antibodies Product and Solutions
Table 28. Genscript Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Genscript Recent Developments and Future Plans
Table 30. Taisho Pharmaceutical Holdings Company Information, Head Office, and Major Competitors
Table 31. Taisho Pharmaceutical Holdings Major Business
Table 32. Taisho Pharmaceutical Holdings Nano Antibodies Product and Solutions
Table 33. Taisho Pharmaceutical Holdings Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Taisho Pharmaceutical Holdings Recent Developments and Future Plans
Table 35. Sensei Biotherapeutics, Inc. Company Information, Head Office, and Major Competitors
Table 36. Sensei Biotherapeutics, Inc. Major Business
Table 37. Sensei Biotherapeutics, Inc. Nano Antibodies Product and Solutions
Table 38. Sensei Biotherapeutics, Inc. Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Sensei Biotherapeutics, Inc. Recent Developments and Future Plans
Table 40. Cusabio Technology LLC. Company Information, Head Office, and Major Competitors
Table 41. Cusabio Technology LLC. Major Business
Table 42. Cusabio Technology LLC. Nano Antibodies Product and Solutions
Table 43. Cusabio Technology LLC. Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Cusabio Technology LLC. Recent Developments and Future Plans
Table 45. ChromoTek GmbH Company Information, Head Office, and Major Competitors
Table 46. ChromoTek GmbH Major Business
Table 47. ChromoTek GmbH Nano Antibodies Product and Solutions
Table 48. ChromoTek GmbH Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. ChromoTek GmbH Recent Developments and Future Plans
Table 50. Beroni Group Company Information, Head Office, and Major Competitors
Table 51. Beroni Group Major Business
Table 52. Beroni Group Nano Antibodies Product and Solutions
Table 53. Beroni Group Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Beroni Group Recent Developments and Future Plans
Table 55. ExeVir Bio BV Company Information, Head Office, and Major Competitors
Table 56. ExeVir Bio BV Major Business
Table 57. ExeVir Bio BV Nano Antibodies Product and Solutions
Table 58. ExeVir Bio BV Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. ExeVir Bio BV Recent Developments and Future Plans
Table 60. Absolute Antibody Company Information, Head Office, and Major Competitors
Table 61. Absolute Antibody Major Business
Table 62. Absolute Antibody Nano Antibodies Product and Solutions
Table 63. Absolute Antibody Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Absolute Antibody Recent Developments and Future Plans
Table 65. Alpalife (Shenzhen kangti Co., Ltd.) Company Information, Head Office, and Major Competitors
Table 66. Alpalife (Shenzhen kangti Co., Ltd.) Major Business
Table 67. Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Product and Solutions
Table 68. Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Alpalife (Shenzhen kangti Co., Ltd.) Recent Developments and Future Plans
Table 70. DiosCURE Therapeutics SE Company Information, Head Office, and Major Competitors
Table 71. DiosCURE Therapeutics SE Major Business
Table 72. DiosCURE Therapeutics SE Nano Antibodies Product and Solutions
Table 73. DiosCURE Therapeutics SE Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. DiosCURE Therapeutics SE Recent Developments and Future Plans
Table 75. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 76. Thermo Fisher Scientific Inc. Major Business
Table 77. Thermo Fisher Scientific Inc. Nano Antibodies Product and Solutions
Table 78. Thermo Fisher Scientific Inc. Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 80. PerkinElmer Inc. (BioLegend, Inc.) Company Information, Head Office, and Major Competitors
Table 81. PerkinElmer Inc. (BioLegend, Inc.) Major Business
Table 82. PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Product and Solutions
Table 83. PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. PerkinElmer Inc. (BioLegend, Inc.) Recent Developments and Future Plans
Table 85. Global Nano Antibodies Revenue (USD Million) by Players (2019-2024)
Table 86. Global Nano Antibodies Revenue Share by Players (2019-2024)
Table 87. Breakdown of Nano Antibodies by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Nano Antibodies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 89. Head Office of Key Nano Antibodies Players
Table 90. Nano Antibodies Market: Company Product Type Footprint
Table 91. Nano Antibodies Market: Company Product Application Footprint
Table 92. Nano Antibodies New Market Entrants and Barriers to Market Entry
Table 93. Nano Antibodies Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Nano Antibodies Consumption Value (USD Million) by Type (2019-2024)
Table 95. Global Nano Antibodies Consumption Value Share by Type (2019-2024)
Table 96. Global Nano Antibodies Consumption Value Forecast by Type (2025-2030)
Table 97. Global Nano Antibodies Consumption Value by Application (2019-2024)
Table 98. Global Nano Antibodies Consumption Value Forecast by Application (2025-2030)
Table 99. North America Nano Antibodies Consumption Value by Type (2019-2024) & (USD Million)
Table 100. North America Nano Antibodies Consumption Value by Type (2025-2030) & (USD Million)
Table 101. North America Nano Antibodies Consumption Value by Application (2019-2024) & (USD Million)
Table 102. North America Nano Antibodies Consumption Value by Application (2025-2030) & (USD Million)
Table 103. North America Nano Antibodies Consumption Value by Country (2019-2024) & (USD Million)
Table 104. North America Nano Antibodies Consumption Value by Country (2025-2030) & (USD Million)
Table 105. Europe Nano Antibodies Consumption Value by Type (2019-2024) & (USD Million)
Table 106. Europe Nano Antibodies Consumption Value by Type (2025-2030) & (USD Million)
Table 107. Europe Nano Antibodies Consumption Value by Application (2019-2024) & (USD Million)
Table 108. Europe Nano Antibodies Consumption Value by Application (2025-2030) & (USD Million)
Table 109. Europe Nano Antibodies Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Nano Antibodies Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Nano Antibodies Consumption Value by Type (2019-2024) & (USD Million)
Table 112. Asia-Pacific Nano Antibodies Consumption Value by Type (2025-2030) & (USD Million)
Table 113. Asia-Pacific Nano Antibodies Consumption Value by Application (2019-2024) & (USD Million)
Table 114. Asia-Pacific Nano Antibodies Consumption Value by Application (2025-2030) & (USD Million)
Table 115. Asia-Pacific Nano Antibodies Consumption Value by Region (2019-2024) & (USD Million)
Table 116. Asia-Pacific Nano Antibodies Consumption Value by Region (2025-2030) & (USD Million)
Table 117. South America Nano Antibodies Consumption Value by Type (2019-2024) & (USD Million)
Table 118. South America Nano Antibodies Consumption Value by Type (2025-2030) & (USD Million)
Table 119. South America Nano Antibodies Consumption Value by Application (2019-2024) & (USD Million)
Table 120. South America Nano Antibodies Consumption Value by Application (2025-2030) & (USD Million)
Table 121. South America Nano Antibodies Consumption Value by Country (2019-2024) & (USD Million)
Table 122. South America Nano Antibodies Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Middle East & Africa Nano Antibodies Consumption Value by Type (2019-2024) & (USD Million)
Table 124. Middle East & Africa Nano Antibodies Consumption Value by Type (2025-2030) & (USD Million)
Table 125. Middle East & Africa Nano Antibodies Consumption Value by Application (2019-2024) & (USD Million)
Table 126. Middle East & Africa Nano Antibodies Consumption Value by Application (2025-2030) & (USD Million)
Table 127. Middle East & Africa Nano Antibodies Consumption Value by Country (2019-2024) & (USD Million)
Table 128. Middle East & Africa Nano Antibodies Consumption Value by Country (2025-2030) & (USD Million)
Table 129. Nano Antibodies Raw Material
Table 130. Key Suppliers of Nano Antibodies Raw Materials
Table 1. Global Nano Antibodies Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Nano Antibodies Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Nano Antibodies Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Nano Antibodies Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Merck KGaA Company Information, Head Office, and Major Competitors
Table 6. Merck KGaA Major Business
Table 7. Merck KGaA Nano Antibodies Product and Solutions
Table 8. Merck KGaA Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Merck KGaA Recent Developments and Future Plans
Table 10. Sanofi (Ablynx) Company Information, Head Office, and Major Competitors
Table 11. Sanofi (Ablynx) Major Business
Table 12. Sanofi (Ablynx) Nano Antibodies Product and Solutions
Table 13. Sanofi (Ablynx) Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Sanofi (Ablynx) Recent Developments and Future Plans
Table 15. Alphamab Oncology Company Information, Head Office, and Major Competitors
Table 16. Alphamab Oncology Major Business
Table 17. Alphamab Oncology Nano Antibodies Product and Solutions
Table 18. Alphamab Oncology Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Alphamab Oncology Recent Developments and Future Plans
Table 20. Novartis AG Company Information, Head Office, and Major Competitors
Table 21. Novartis AG Major Business
Table 22. Novartis AG Nano Antibodies Product and Solutions
Table 23. Novartis AG Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Novartis AG Recent Developments and Future Plans
Table 25. Genscript Company Information, Head Office, and Major Competitors
Table 26. Genscript Major Business
Table 27. Genscript Nano Antibodies Product and Solutions
Table 28. Genscript Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Genscript Recent Developments and Future Plans
Table 30. Taisho Pharmaceutical Holdings Company Information, Head Office, and Major Competitors
Table 31. Taisho Pharmaceutical Holdings Major Business
Table 32. Taisho Pharmaceutical Holdings Nano Antibodies Product and Solutions
Table 33. Taisho Pharmaceutical Holdings Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Taisho Pharmaceutical Holdings Recent Developments and Future Plans
Table 35. Sensei Biotherapeutics, Inc. Company Information, Head Office, and Major Competitors
Table 36. Sensei Biotherapeutics, Inc. Major Business
Table 37. Sensei Biotherapeutics, Inc. Nano Antibodies Product and Solutions
Table 38. Sensei Biotherapeutics, Inc. Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Sensei Biotherapeutics, Inc. Recent Developments and Future Plans
Table 40. Cusabio Technology LLC. Company Information, Head Office, and Major Competitors
Table 41. Cusabio Technology LLC. Major Business
Table 42. Cusabio Technology LLC. Nano Antibodies Product and Solutions
Table 43. Cusabio Technology LLC. Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Cusabio Technology LLC. Recent Developments and Future Plans
Table 45. ChromoTek GmbH Company Information, Head Office, and Major Competitors
Table 46. ChromoTek GmbH Major Business
Table 47. ChromoTek GmbH Nano Antibodies Product and Solutions
Table 48. ChromoTek GmbH Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. ChromoTek GmbH Recent Developments and Future Plans
Table 50. Beroni Group Company Information, Head Office, and Major Competitors
Table 51. Beroni Group Major Business
Table 52. Beroni Group Nano Antibodies Product and Solutions
Table 53. Beroni Group Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Beroni Group Recent Developments and Future Plans
Table 55. ExeVir Bio BV Company Information, Head Office, and Major Competitors
Table 56. ExeVir Bio BV Major Business
Table 57. ExeVir Bio BV Nano Antibodies Product and Solutions
Table 58. ExeVir Bio BV Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. ExeVir Bio BV Recent Developments and Future Plans
Table 60. Absolute Antibody Company Information, Head Office, and Major Competitors
Table 61. Absolute Antibody Major Business
Table 62. Absolute Antibody Nano Antibodies Product and Solutions
Table 63. Absolute Antibody Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Absolute Antibody Recent Developments and Future Plans
Table 65. Alpalife (Shenzhen kangti Co., Ltd.) Company Information, Head Office, and Major Competitors
Table 66. Alpalife (Shenzhen kangti Co., Ltd.) Major Business
Table 67. Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Product and Solutions
Table 68. Alpalife (Shenzhen kangti Co., Ltd.) Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Alpalife (Shenzhen kangti Co., Ltd.) Recent Developments and Future Plans
Table 70. DiosCURE Therapeutics SE Company Information, Head Office, and Major Competitors
Table 71. DiosCURE Therapeutics SE Major Business
Table 72. DiosCURE Therapeutics SE Nano Antibodies Product and Solutions
Table 73. DiosCURE Therapeutics SE Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. DiosCURE Therapeutics SE Recent Developments and Future Plans
Table 75. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 76. Thermo Fisher Scientific Inc. Major Business
Table 77. Thermo Fisher Scientific Inc. Nano Antibodies Product and Solutions
Table 78. Thermo Fisher Scientific Inc. Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 80. PerkinElmer Inc. (BioLegend, Inc.) Company Information, Head Office, and Major Competitors
Table 81. PerkinElmer Inc. (BioLegend, Inc.) Major Business
Table 82. PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Product and Solutions
Table 83. PerkinElmer Inc. (BioLegend, Inc.) Nano Antibodies Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. PerkinElmer Inc. (BioLegend, Inc.) Recent Developments and Future Plans
Table 85. Global Nano Antibodies Revenue (USD Million) by Players (2019-2024)
Table 86. Global Nano Antibodies Revenue Share by Players (2019-2024)
Table 87. Breakdown of Nano Antibodies by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Nano Antibodies, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 89. Head Office of Key Nano Antibodies Players
Table 90. Nano Antibodies Market: Company Product Type Footprint
Table 91. Nano Antibodies Market: Company Product Application Footprint
Table 92. Nano Antibodies New Market Entrants and Barriers to Market Entry
Table 93. Nano Antibodies Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Nano Antibodies Consumption Value (USD Million) by Type (2019-2024)
Table 95. Global Nano Antibodies Consumption Value Share by Type (2019-2024)
Table 96. Global Nano Antibodies Consumption Value Forecast by Type (2025-2030)
Table 97. Global Nano Antibodies Consumption Value by Application (2019-2024)
Table 98. Global Nano Antibodies Consumption Value Forecast by Application (2025-2030)
Table 99. North America Nano Antibodies Consumption Value by Type (2019-2024) & (USD Million)
Table 100. North America Nano Antibodies Consumption Value by Type (2025-2030) & (USD Million)
Table 101. North America Nano Antibodies Consumption Value by Application (2019-2024) & (USD Million)
Table 102. North America Nano Antibodies Consumption Value by Application (2025-2030) & (USD Million)
Table 103. North America Nano Antibodies Consumption Value by Country (2019-2024) & (USD Million)
Table 104. North America Nano Antibodies Consumption Value by Country (2025-2030) & (USD Million)
Table 105. Europe Nano Antibodies Consumption Value by Type (2019-2024) & (USD Million)
Table 106. Europe Nano Antibodies Consumption Value by Type (2025-2030) & (USD Million)
Table 107. Europe Nano Antibodies Consumption Value by Application (2019-2024) & (USD Million)
Table 108. Europe Nano Antibodies Consumption Value by Application (2025-2030) & (USD Million)
Table 109. Europe Nano Antibodies Consumption Value by Country (2019-2024) & (USD Million)
Table 110. Europe Nano Antibodies Consumption Value by Country (2025-2030) & (USD Million)
Table 111. Asia-Pacific Nano Antibodies Consumption Value by Type (2019-2024) & (USD Million)
Table 112. Asia-Pacific Nano Antibodies Consumption Value by Type (2025-2030) & (USD Million)
Table 113. Asia-Pacific Nano Antibodies Consumption Value by Application (2019-2024) & (USD Million)
Table 114. Asia-Pacific Nano Antibodies Consumption Value by Application (2025-2030) & (USD Million)
Table 115. Asia-Pacific Nano Antibodies Consumption Value by Region (2019-2024) & (USD Million)
Table 116. Asia-Pacific Nano Antibodies Consumption Value by Region (2025-2030) & (USD Million)
Table 117. South America Nano Antibodies Consumption Value by Type (2019-2024) & (USD Million)
Table 118. South America Nano Antibodies Consumption Value by Type (2025-2030) & (USD Million)
Table 119. South America Nano Antibodies Consumption Value by Application (2019-2024) & (USD Million)
Table 120. South America Nano Antibodies Consumption Value by Application (2025-2030) & (USD Million)
Table 121. South America Nano Antibodies Consumption Value by Country (2019-2024) & (USD Million)
Table 122. South America Nano Antibodies Consumption Value by Country (2025-2030) & (USD Million)
Table 123. Middle East & Africa Nano Antibodies Consumption Value by Type (2019-2024) & (USD Million)
Table 124. Middle East & Africa Nano Antibodies Consumption Value by Type (2025-2030) & (USD Million)
Table 125. Middle East & Africa Nano Antibodies Consumption Value by Application (2019-2024) & (USD Million)
Table 126. Middle East & Africa Nano Antibodies Consumption Value by Application (2025-2030) & (USD Million)
Table 127. Middle East & Africa Nano Antibodies Consumption Value by Country (2019-2024) & (USD Million)
Table 128. Middle East & Africa Nano Antibodies Consumption Value by Country (2025-2030) & (USD Million)
Table 129. Nano Antibodies Raw Material
Table 130. Key Suppliers of Nano Antibodies Raw Materials
LIST OF FIGURES
Figure 1. Nano Antibodies Picture
Figure 2. Global Nano Antibodies Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Nano Antibodies Consumption Value Market Share by Type in 2023
Figure 4. Monovalent Nanobody
Figure 5. Multivalent and multispecific Nanobodies
Figure 6. Fusion Nanobody
Figure 7. Global Nano Antibodies Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Nano Antibodies Consumption Value Market Share by Application in 2023
Figure 9. Disease detection in vitro Picture
Figure 10. Non-invasive diagnosis in vivo Picture
Figure 11. Tumor targeted therapy Picture
Figure 12. Nervous system disease Picture
Figure 13. Circulatory disease Picture
Figure 14. Infectious disease Picture
Figure 15. Other Picture
Figure 16. Global Nano Antibodies Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Nano Antibodies Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Market Nano Antibodies Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 19. Global Nano Antibodies Consumption Value Market Share by Region (2019-2030)
Figure 20. Global Nano Antibodies Consumption Value Market Share by Region in 2023
Figure 21. North America Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East and Africa Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Nano Antibodies Revenue Share by Players in 2023
Figure 27. Nano Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 28. Global Top 3 Players Nano Antibodies Market Share in 2023
Figure 29. Global Top 6 Players Nano Antibodies Market Share in 2023
Figure 30. Global Nano Antibodies Consumption Value Share by Type (2019-2024)
Figure 31. Global Nano Antibodies Market Share Forecast by Type (2025-2030)
Figure 32. Global Nano Antibodies Consumption Value Share by Application (2019-2024)
Figure 33. Global Nano Antibodies Market Share Forecast by Application (2025-2030)
Figure 34. North America Nano Antibodies Consumption Value Market Share by Type (2019-2030)
Figure 35. North America Nano Antibodies Consumption Value Market Share by Application (2019-2030)
Figure 36. North America Nano Antibodies Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe Nano Antibodies Consumption Value Market Share by Type (2019-2030)
Figure 41. Europe Nano Antibodies Consumption Value Market Share by Application (2019-2030)
Figure 42. Europe Nano Antibodies Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 44. France Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Nano Antibodies Consumption Value Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Nano Antibodies Consumption Value Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Nano Antibodies Consumption Value Market Share by Region (2019-2030)
Figure 51. China Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 52. Japan Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 53. South Korea Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 54. India Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 55. Southeast Asia Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 56. Australia Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 57. South America Nano Antibodies Consumption Value Market Share by Type (2019-2030)
Figure 58. South America Nano Antibodies Consumption Value Market Share by Application (2019-2030)
Figure 59. South America Nano Antibodies Consumption Value Market Share by Country (2019-2030)
Figure 60. Brazil Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 61. Argentina Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 62. Middle East and Africa Nano Antibodies Consumption Value Market Share by Type (2019-2030)
Figure 63. Middle East and Africa Nano Antibodies Consumption Value Market Share by Application (2019-2030)
Figure 64. Middle East and Africa Nano Antibodies Consumption Value Market Share by Country (2019-2030)
Figure 65. Turkey Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 66. Saudi Arabia Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 67. UAE Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 68. Nano Antibodies Market Drivers
Figure 69. Nano Antibodies Market Restraints
Figure 70. Nano Antibodies Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Nano Antibodies in 2023
Figure 73. Manufacturing Process Analysis of Nano Antibodies
Figure 74. Nano Antibodies Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
Figure 1. Nano Antibodies Picture
Figure 2. Global Nano Antibodies Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Nano Antibodies Consumption Value Market Share by Type in 2023
Figure 4. Monovalent Nanobody
Figure 5. Multivalent and multispecific Nanobodies
Figure 6. Fusion Nanobody
Figure 7. Global Nano Antibodies Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 8. Nano Antibodies Consumption Value Market Share by Application in 2023
Figure 9. Disease detection in vitro Picture
Figure 10. Non-invasive diagnosis in vivo Picture
Figure 11. Tumor targeted therapy Picture
Figure 12. Nervous system disease Picture
Figure 13. Circulatory disease Picture
Figure 14. Infectious disease Picture
Figure 15. Other Picture
Figure 16. Global Nano Antibodies Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Nano Antibodies Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Market Nano Antibodies Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 19. Global Nano Antibodies Consumption Value Market Share by Region (2019-2030)
Figure 20. Global Nano Antibodies Consumption Value Market Share by Region in 2023
Figure 21. North America Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East and Africa Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Nano Antibodies Revenue Share by Players in 2023
Figure 27. Nano Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 28. Global Top 3 Players Nano Antibodies Market Share in 2023
Figure 29. Global Top 6 Players Nano Antibodies Market Share in 2023
Figure 30. Global Nano Antibodies Consumption Value Share by Type (2019-2024)
Figure 31. Global Nano Antibodies Market Share Forecast by Type (2025-2030)
Figure 32. Global Nano Antibodies Consumption Value Share by Application (2019-2024)
Figure 33. Global Nano Antibodies Market Share Forecast by Application (2025-2030)
Figure 34. North America Nano Antibodies Consumption Value Market Share by Type (2019-2030)
Figure 35. North America Nano Antibodies Consumption Value Market Share by Application (2019-2030)
Figure 36. North America Nano Antibodies Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe Nano Antibodies Consumption Value Market Share by Type (2019-2030)
Figure 41. Europe Nano Antibodies Consumption Value Market Share by Application (2019-2030)
Figure 42. Europe Nano Antibodies Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 44. France Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Nano Antibodies Consumption Value Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Nano Antibodies Consumption Value Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Nano Antibodies Consumption Value Market Share by Region (2019-2030)
Figure 51. China Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 52. Japan Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 53. South Korea Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 54. India Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 55. Southeast Asia Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 56. Australia Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 57. South America Nano Antibodies Consumption Value Market Share by Type (2019-2030)
Figure 58. South America Nano Antibodies Consumption Value Market Share by Application (2019-2030)
Figure 59. South America Nano Antibodies Consumption Value Market Share by Country (2019-2030)
Figure 60. Brazil Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 61. Argentina Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 62. Middle East and Africa Nano Antibodies Consumption Value Market Share by Type (2019-2030)
Figure 63. Middle East and Africa Nano Antibodies Consumption Value Market Share by Application (2019-2030)
Figure 64. Middle East and Africa Nano Antibodies Consumption Value Market Share by Country (2019-2030)
Figure 65. Turkey Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 66. Saudi Arabia Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 67. UAE Nano Antibodies Consumption Value (2019-2030) & (USD Million)
Figure 68. Nano Antibodies Market Drivers
Figure 69. Nano Antibodies Market Restraints
Figure 70. Nano Antibodies Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Nano Antibodies in 2023
Figure 73. Manufacturing Process Analysis of Nano Antibodies
Figure 74. Nano Antibodies Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
